Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2023-07-05 00:00:00 ET · period of report 2023-06-30 · accession 0001209191-23-041333 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-07-05 | 2023-06-30+ | MIRM | Howe Jolanda | SVP, Gbl Ctrl | M - OptEx | — | +2,605 | 4,374 | +147% | — |
| D | 2023-07-05 | 2023-07-03 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | S - Sale+OE | $25.65 | -915 | 3,459 | -21% | -$23.5K |
| DM | 2023-07-05 | 2023-06-30+ | MIRM | Howe Jolanda | SVP, Gbl Ctrl | M - OptEx | $0.00 | -2,605 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-30 | M | A | 1,563 | — | 3,332 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). |
| 2 | Common | Common Stock | 2023-07-03 | S | D | 915 | $25.65 | 3,459 | D | — | — | |
| 3 | Common | Common Stock | 2023-07-01 | M | A | 1,042 | — | 4,374 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). |
| 4 | Derivative | Restricted Stock Units | 2023-07-01 | M | D | 1,042 | $0.00 | 2,083 | D | — · — to — | 1,042 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). (F4) The restricted stock units vest in a series of three successive equal annual installments beginning July 1, 2023. |
| 5 | Derivative | Performance Restricted Stock Units | 2023-06-30 | M | D | 1,563 | $0.00 | 0 | D | — · — to — | 1,563 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). (F3) On March 9, 2021, the reporting person was granted performance-based restricted stock units ("PSUs"), which vest upon the satisfaction of certain performance criteria. On September 29, 2021, such performance criteria were met. 1,562 shares subject to the PSUs vested on September 29, 2021, and 1,563 shares vested on June 30, 2023. |